azacitidine,venetoclax,pivekimab sunirine
abbvie,roche,immunogen,Jazz Pharmaceuticals
['aza+', 'venetoclax', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'venclexta', 'pivekimab', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia', 'myeloid', ' elo ', 'jazz', 'imab ', '$imgn', '$jazz']
pivekimab sunirine (imgn632) aza+venclexta combo in cd123+ve r/r aml. this is the asset $jazz didn't opt in to in dec 2020. #ash22 slides via naval daver $imgn 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.